Weng Tzu-Han, Pien Yu-Chung, Chen Ching-Jou, Chen Po-Pang, Tseng Yu-Ting, Chen Ying-Chen, Hsiao Wen-Po, Lee Ying-Ting, Chen Yi-An, Chen Yao-Chi, Lim Carmay, Hsu Tzu-Han, Lin Sung-Jan, Yen Hsin-Yung, Hsia Kuo-Chiang, Tsai Su-Yi
Department of Life Science, National Taiwan University, Taipei, Taiwan.
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan.
Nat Commun. 2025 Jul 16;16(1):6556. doi: 10.1038/s41467-025-61862-3.
Proper regulation of glycogen metabolism is fundamental to cellular energy homeostasis, and its disruption is associated with various metabolic disorders, including glycogen storage diseases (GSDs) and potentially diabetes. Despite glycogen's role as an essential energy reservoir, the mechanisms governing its synthesis and structural diversity across tissues remain unclear. Here, we uncover the distinct physiological roles of the human glycogenins GYG1 and GYG2 in glycogen synthesis. Through cellular models, structural biology, and biochemical analyses, we demonstrate that, unlike GYG1, GYG2 exhibits minimal autoglycosylation activity and acts as a suppressor of glycogen formation. Together, these two glycogenins coordinate glycogen synthase activity and influence glycogen assembly in a cell-type-dependent manner. Importantly, these glycogenins modulate glucose metabolic pathways, thereby ensuring cellular glucose homeostasis. These findings address longstanding questions in glycogen metabolism and establish both GYG1 and GYG2 as critical regulators of glycogen synthesis and breakdown in human, providing insights with potential therapeutic implications for treating GSDs and metabolic diseases.
糖原代谢的适当调节是细胞能量稳态的基础,其紊乱与各种代谢紊乱有关,包括糖原贮积病(GSDs)以及潜在的糖尿病。尽管糖原作为重要的能量储存库发挥着作用,但调控其在不同组织中的合成及结构多样性的机制仍不清楚。在此,我们揭示了人类糖原合酶GYG1和GYG2在糖原合成中的不同生理作用。通过细胞模型、结构生物学和生化分析,我们证明,与GYG1不同,GYG2表现出最小的自糖基化活性,并作为糖原形成的抑制剂发挥作用。这两种糖原合酶共同以细胞类型依赖的方式协调糖原合酶活性并影响糖原组装。重要的是,这些糖原合酶调节葡萄糖代谢途径,从而确保细胞葡萄糖稳态。这些发现解决了糖原代谢中长期存在的问题,并确立了GYG1和GYG2都是人类糖原合成和分解的关键调节因子,为治疗GSDs和代谢疾病提供了具有潜在治疗意义的见解。